73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
A feasibility study for salvage radiation therapy in prostate cancer

A feasibility study for salvage radiation therapy in prostate cancer

by Impact Journals LLCCredit: CC0 Public DomainAn editorial paper waspublishedinOncoscienceon May 20, 2024, titled, "Deep learning-assisted lesion segmentation in PET/CT i

A feasibility study for salvage radiation therapy in prostate cancer

by Impact Journals LLCCredit: CC0 Public DomainAn editorial paper waspublishedinOncoscienceon May 20, 2024, titled, "Deep learning-assisted lesion segmentation in PET/CT i
New therapeutic vaccine gives hope against an aggressive breast cancer

New therapeutic vaccine gives hope against an aggressive breast cancer

by Dennis ThompsonAn experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests.The vaccine appears to be safe and

New therapeutic vaccine gives hope against an aggressive breast cancer

by Dennis ThompsonAn experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests.The vaccine appears to be safe and
Older US adults with certain preexisting conditions often diagnosed with poor prognosis cancers

Older US adults with certain preexisting conditions often diagnosed with poor prognosis cancers

byWileyCredit: Pixabay/CC0 Public DomainA recent analysis published in theJournal of the American Geriatrics Societyfound that before older U.S. adults were diagnosed with poor prognosis c

Older US adults with certain preexisting conditions often diagnosed with poor prognosis cancers

byWileyCredit: Pixabay/CC0 Public DomainA recent analysis published in theJournal of the American Geriatrics Societyfound that before older U.S. adults were diagnosed with poor prognosis c
New tool combines evolution and AI to predict prostate cancer recurrence more than a decade ahead

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade ahead

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade aheadbyInstitute of Cancer ResearchStudy design. Credit:Nature Cancer(2024). DOI: 10.1038/

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade ahead

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade aheadbyInstitute of Cancer ResearchStudy design. Credit:Nature Cancer(2024). DOI: 10.1038/
FDA approves new treatment for advanced melanoma

FDA approves new treatment for advanced melanoma

by Robin FosterThe U.S. Food and Drug Administration has approved a novel treatment for advanced melanoma, the most deadly form of skin cancer.Amtagvi, made by Iovance Biotherapeutics Inc., becomes th

FDA approves new treatment for advanced melanoma

by Robin FosterThe U.S. Food and Drug Administration has approved a novel treatment for advanced melanoma, the most deadly form of skin cancer.Amtagvi, made by Iovance Biotherapeutics Inc., becomes th
Study finds 95 percent satisfaction rate with Mohs surgery

Study finds 95 percent satisfaction rate with Mohs surgery

by Patrick McGee,UT Southwestern Medical CenterPatients who received Mohs surgery to treat the most serious form of skin cancer, melanoma, reported a 95 percent long-term satisfaction rate with

Study finds 95 percent satisfaction rate with Mohs surgery

by Patrick McGee,UT Southwestern Medical CenterPatients who received Mohs surgery to treat the most serious form of skin cancer, melanoma, reported a 95 percent long-term satisfaction rate with
'No one should cancel their colonoscopies': Addressing controversy from a recent clinical trial

'No one should cancel their colonoscopies': Addressing controversy from a recent clinical trial

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainDespite some confusing messages this week around the value of colonoscopies, Wilmot Cancer Institute physici

'No one should cancel their colonoscopies': Addressing controversy from a recent clinical trial

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainDespite some confusing messages this week around the value of colonoscopies, Wilmot Cancer Institute physici
Protein partnership effectively fends off pancreatic cancer progression

Protein partnership effectively fends off pancreatic cancer progression

byVirginia Commonwealth UniversityModel for the functional interaction between Smad4 and Prdm16 during PDAC formation and progression. Credit:Journal of Cell Biology(2023). DOI: 10.1

Protein partnership effectively fends off pancreatic cancer progression

byVirginia Commonwealth UniversityModel for the functional interaction between Smad4 and Prdm16 during PDAC formation and progression. Credit:Journal of Cell Biology(2023). DOI: 10.1
Cancer study may accidentally help researchers create usable blood stem cells

Cancer study may accidentally help researchers create usable blood stem cells

by Garth Sundem,CU Anschutz Medical CampusBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaA massive research effort over more than a quarter

Cancer study may accidentally help researchers create usable blood stem cells

by Garth Sundem,CU Anschutz Medical CampusBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaA massive research effort over more than a quarter
Guideline updated for initial management of advanced prostate cancer

Guideline updated for initial management of advanced prostate cancer

by Elana GotkineFor patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen depri

Guideline updated for initial management of advanced prostate cancer

by Elana GotkineFor patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen depri